June 2026
The mRNA vaccines and therapeutics market size reached USD 116.88 billion in 2025 and is projected to surpass around USD 297.84 billion by 2035 with a CAGR of 9.81%.
May 2026
The mRNA therapeutics market size was valued at USD 20.83 billion in 2025 and is expected to hit around USD 45.40 billion by 2035, growing at a CAGR of 8.1%.
April 2026
The global mRNA therapeutics CDMO market size is estimated to hit around USD 14.63 billion by 2035 from USD 5.66 billion in 2026, with a CAGR of 11.14%.
July 2025
The U.S. mRNA therapeutics market size was estimated at USD 5.48 billion in 2025 and is projected to hit USD 12.70 billion by 2036, with a notable CAGR of 8.77%
July 2026
The global gene editing & mRNA tool kits market is driving advancements in gene therapy, synthetic biology, and molecular diagnostics worldwide
September 2026
The brain health supplements and therapeutics market size was USD 20.42 billion in 2026, with leading brain health supplements and therapeutics market players including Neuriva, Prevagen, Danone, Nestlé Health Science.
September 2026
The cancer therapeutics and biotherapeutics market size reached USD 228.73 billion in 2026, with leading cancer therapeutics and biotherapeutics market companies including Amgen Inc., Bristol-Myers Squibb, Celgene Corporation.
August 2026
The homecare diagnostics & therapeutics market size accounted for USD 269.92 billion in 2025 and is expected to hit USD 577.56 billion by 2035, with a CAGR of 7.90%.
July 2026
The digital therapeutics and connected care market established a strong position in 2026 and is projected to expand significantly from 2026 through 2035, driven by increasing demand, evolving market needs, technological advancements, and growing adoption across key industries..
June 2026
The global exosome therapeutics market size is evaluated at USD 928.93 thousand in 2025 and is predicted to hit around USD 4,564.32 thousand by 2035, with a CAGR of 17.26%.
March 2026
The global allergy diagnostics and therapeutics market size is expected to hit around USD 75.07 billion by 2035 from USD 38.76 billion in 2025 with a CAGR of 6.83%.
February 2026
The global mRNA synthesis and manufacturing market size is estimated to hit around USD 5.64 billion by 2035 increasing from USD 3.19 billion in 2025, with a CAGR of 5.85%.
December 2025
The global dermatology diagnostic devices and therapeutics market size is projected to hit around USD 31.33 billion by 2035 from USD 15.90 billion in 2025, with a CAGR of 7.02%.
September 2026
The global melanoma therapeutics market size accounted for USD 8.16 billion in 2026 and is expected to hit around USD 19.61 billion by 2035, at a CAGR of 10.25%.
September 2026
The global targeted therapeutics market size was estimated at USD 91.76 billion in 2026 and is projected to hit around USD 163.91 billion by 2035 with a CAGR of 6.69%.
September 2026
The global non-Hodgkin's lymphoma therapeutics market size is estimated to hit around USD 20.94 billion by 2034, increasing from USD 11.80 billion in 2026, with a CAGR of 7.43%.
September 2026
The anti-inflammatory therapeutics market size was estimated at USD 113.58 billion in 2026 and is expected to hit USD 164.44 billion by 2035, with a CAGR of 4.14%.
September 2026
The global narcolepsy therapeutics market size is accounted at USD 4.46 billion in 2026 and is expected to hit around USD 9.31 billion by 2035 with a CAGR of 8.49%.
September 2026
The pediatric vaccines market size was valued at USD 70.38 billion in 2026 and is expected to attain around USD 117.32 billion by 2035 with a CAGR of 5.86%.
September 2026
The global women's health therapeutics market size is predicted to hit around USD 66.62 billion by 2034 from USD 48.57 billion in 2026, with a CAGR of 4.03%.
September 2026
The global fallopian tube cancer therapeutics market size is expected to increase from USD 2.14 billion in 2026 to hit around USD 5.41 billion by 2035, growing at a CAGR of 10.86%.
September 2026
The global plasma therapeutics market size is estimated to hit around USD 52.26 billion by 2035 increasing from USD 28.35 billion in 2025, with a CAGR of 6.31%.
September 2026
The global plasma protein therapeutics market size is projected to cross around USD 48.43 billion by 2034 from USD 32.66 billion in 2026 with a CAGR of 5.06%.
September 2026
The global colorectal cancer therapeutics market size is expected to hit around USD 19.95 billion by 2034 from USD 12.79 billion in 2024 with a CAGR of 4.55%.
September 2026
The sepsis therapeutics market size was valued at USD 4,27 billion in 2026 and is expected to Attain around USD 7.36 billion by 2034 with a CAGR of 7.06%.
September 2026
The global digital therapeutics market size was exhibited at USD 11.98 billion in 2026 and is projected to surpass around USD 65.31 billion by 2035, with a remarkable CAGR of 20.97%.
September 2026
The pain management therapeutics market size accounted for USD 91.54 billion in 2026 and is predicted to hit around USD 127.78 billion by 2035, with a CAGR of 3.78%.
September 2026
The global multiple sclerosis therapeutics market size was evaluated at USD 37.16 billion in 2026 and is predicted to hit around USD 66.80 billion by 2035, growing at a CAGR of 6.90%.
September 2026
The global breast cancer therapeutics market size was valued at USD 35.91 billion in 2026 and is expected to hit around USD 66.72 billion by 2035, at a CAGR of 7.27%.
September 2026
The tau protein targeting therapeutics market size reached USD 1,314.50 million in 2026, with leading tau protein targeting therapeutics market companies including Biogen Inc., F. Hoffmann-La Roche Ltd., Eli Lilly and Company, AbbVie Inc.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com